Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02514265 · ClinicalTrials.gov registry record
Trans-MAPP Symptom Patterns Study (SPS)
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 640
- Enrollment target
NCT02514265: Completed study, sponsored by University of Pennsylvania.
NCT02514265 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 640 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02514265 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 640 participants
- Enrollment target
Study Summary
This study is the second phase of the MAPP Network and is designed to conduct a prospective, observational study of men and women with UCPPS, referred to as the Symptom Patterns Study (SPS), enriched with pre-defined subgroups, with longer follow-up, in order to further investigate clinical and biologic factors associated with worsening and/or improvement of reported urinary and non-urinary symptoms.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 640 participants |
| Start Date | 2015-07-01 |
| Est. Completion | 2020-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02514265
The ClinicalTrials.gov registry entry for NCT02514265 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 640 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02514265 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02514265 about?
NCT02514265 is a clinical study titled "Trans-MAPP Symptom Patterns Study (SPS)". This study is the second phase of the MAPP Network and is designed to conduct a prospective, observational study of men and women with UCPPS, referred to as the Symptom Patterns Study (SPS), enriched with pre-defined subgroups, with longer follow-up, in order to further investigate clinical and biol...
What is the current status of trial NCT02514265?
This trial is currently completed. The enrollment target is 640 participants. The study started on 2015-07-01. Estimated completion is 2020-06.
Who is sponsoring clinical trial NCT02514265?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.